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Abstract
Stimulants have been shown to have a variety of effects on different measures of learning
and memory. In general low doses of stimulants like nicotine and caffeine enhance memory
acquisition and recall, while high doses can significantly impair performance. Amphetamine, in
the form of Adderall, is widely prescribed to improve attention and reduce hyperactivity, which
promotes learning in children diagnosed with attention deficit disorder (ADHD). The radial arm
maze (RAM) is a test of spatial learning that allows for the tracking of short and long-term
memory errors. In the current study, we employed the RAM to examine the effects of
amphetamine on spatial learning performance in spontaneously hypertensive rat (SHR), an
accepted model of ADHD, animals and age/strain matched controls. An immunohisotchemical
analysis of cFos expression in the hippocampus was also utilized to evaluate the effect of
amphetamine of neural activation in both groups of animals. Amphetamine (1.0 mg/kg, ip)
administered during training significantly increased maze completion time and increased shortterm and long-term error rates. The results of this study suggest that chronic amphetamine
treatments have hindering effects on learning and memory in control rats. Unlike their
age/strain matched controls, amphetamine did not enhance or inhibit radial arm maze
performance of SHR animals. This suggests that the neurophysiological mechanisms mediating
learning and memory may be different in SHR animals than in humans with ADHD. Therefore,
additional studies are needed to evaluate the validity of the SHR model of ADHD.
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Introduction
1.1 Attention-deficit Hyperactivity Disorder: An Overview
George Still gave the first description of ADHD in the Coombs lecture of 1902. Still
described ADHD as an “abnormal defect in moral control in children (Still, 1905).” And he
defined moral control as “the control in action of conformity with the idea of the good of all…
(that) can only exist when there is a cognitive relationship to the environment (Still, 1905).” He
believed that moral control required a “consciousness” that informed the capacity of “inhibitory
volition (Still, 1905).” Attention-deficit Hyperactivity Disorder (ADHD) is the most common
childhood-onset psychiatric disorder affecting an estimated 4.1 percent of adults in a given year.
Comparatively to other psychiatric disorders, 3.1 percent of adults have generalized anxiety
disorder, 3.5 percent of the adult population has post-traumatic stress disorder, 1.0 percent of
people have OCD, and 1.1 percent of the adults have schizophrenia, and 9.5 percent of the U.S.
adult population has a mood disorder in a given year (Merikangas, 2010). Therefore, ADHD is a
very prevalent disorder among adults and children. The resulting behavioral hindrances often
lead to impaired social and academic functioning. ADHD results in a high degree of inattention
with or without hyperactivity and impulsivity behavior (Sharp, McQuillin, & Gurling, 2009).
ADHD is a multifactorial disorder with complex etiology and strong genetic
underpinnings. Most cases of ADHD are comorbid with other behavioral syndromes or
neurodevelopmental patterns, and it is very unusual to find it in pure form (Hill, 2005). There
does not seem to be any one cause, and ADHD appears to be more a case of risk factors and the
major risk factor being genetics. Also, several predictors of the disorder that have been identified
which include family history of ADHD, psychiatric comorbidity and psychosocial adversity
(Biederman et al, 1995). The risk of having ADHD increases as the number of risk factors
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increase. ADHD is worldwide and possibly affects five to ten percent of children and four
percent of adults (Faraone et al., 2003). It is a heterogeneous disorder; however, ADHD is four
times more common in boys than girls which is similar to other neurodevelopmental disorders
such as autism, specific reading disorders, and specific developmental disorders of speech and
language (Hill, 2005). The disorder affects not only the afflicted but puts huge financial strain on
society, stress to families, and adverse academic and vocational outcomes (Biederman, 2005).
According to Faraone et al. (2005), the inattentive component of ADHD is manifested by
daydreaming, distractibility, and difficulty focusing on a single task for a prolonged period,
whereas the hyperactivity component is expressed as fidgeting, excessive talking, and
restlessness (Biederman, 2005). Those that have ADHD symptoms are more prone to accidents,
mood disorders, anxiety, delinquency, have strained interpersonal relationships, and are
disruptive to those around them through interruptions and inappropriate behavior. Childhood
ADHD is especially worrisome because it predicts adult alcoholism and substance dependence
(Clure et al, 1999). Throughout development the overt symptoms of hyperactivity tend to wane
in the early part of life but the more covert symptoms of inattention seem to persist over time
(Biederman, et al 1996).

1.2 Diagnostic Criteria
The diagnosis in the 1930s for a child that exhibited hyperkinesis, impulsivity, learning
disability, and short attention span was described as minimal brain damage and then as minimal
brain dysfunction since his or her symptoms were very much like patients that had central
nervous system injuries. In the 1950s the label was adjusted to hyperactive child syndrome and
then the Diagnostic Statistical Manual of Mental Disorders (DSM)-II adjusted the label to
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hyperkinetic reaction of childhood (Spencer et al., 2007). The labels presented focused on
motoric hyperactivity and overt impulsivity as the traits of the ADHD. In the DSM-III the focus
shifted to inattention as one of the main traits of ADHD. In addition, the DSM-III addressed the
varying degrees of the presentation of the disorder at different ages, as well as, recognizing that
there is a form of ADHD that persists past childhood. The DSM-IV now defines ADHD as
having three subtypes including predominately inattentive, predominately hyperactive-impulsive,
and a combined subtype. For a diagnosis of a specific subtype the child must exhibit at least six
or greater of the nine symptoms in each subtype classification. There are four additional criteria
that include age of onset by seven, ADHD-specific adaptive impairments, and separation from
other existing conditions (Spencer et al, 2007). The diagnostic assessment of children includes
interviewing the parent, individual assessment of the child, interviewing the child, and
information from the school. The parents are interviewed to obtain developmental history as well
as information about the child’s current behavior. The child is assessed by giving them complex
cognitive tasks, such as reading, model-building, and writing and drawing. As the child performs
the assigned task the clinician observes the child’s behaviors. This step is especially important so
that the clinician can make sure that the child’s symptoms are not from some other type of
impairment, such as deafness. The child is interviewed to understand the child’s school
environment, peer group functioning, self-esteem and illicit habits (Hill, 2005). The child’s
teachers are asked to fill out the Connor’s teacher rating scale, which includes ratings of
oppositional, cognitive problems and inattention, hyperactivity, anxious, perfectionism, and
social problems, and teachers are asked to add their comments on the child’s behaviors,
academic achievement, and social relationships. All the information collected is assessed to see
if ADHD is likely, to see if there are comorbid conditions, to create a baseline of functioning, to
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determine the fitness of the child for medication, to assess the families attitude toward the child,
and to estimate the child’s intellectual functioning (Hill, 2005). A thorough evaluation of all the
previous assessments allows for the professional diagnosis of ADHD.

1.3 Causes of ADHD
Although the cause of ADHD is not entirely known, many studies have suggested that the
disorder has genetic components. In order to determine if a disorder is heritable, genetic linkage
studies are performed. Linkage analysis is a method used for identifying the presence of
susceptibility genes for a genetic disorder within regions of chromosome. The presence of
linkage is usually expressed as log10 of the odds (lod) score for the probability of observing
marker alleles co-segregating with the disorder in multiple affected families compared to the null
hypothesis of no co-segregation or 50% recombination between marker alleles and the disease.
There is also another approach to determining if a disorder is genetic called the sib pair linkage
method. In this method marker alleles are observed in affected siblings to test the hypothesis that
they are shared in affected cases more than by chance. In heterogeneous disorders, such as
ADHD, small or medium sized families have the power to detect different genetic subtypes, as
defined by positive lods at linkage hotspots, whereas the affected sib pair linkage method has
little or no power to detect heterogeneity. In order to identify which gene is involved in ADHD
once a linked region has been confirmed using the lod or sib pair method, the evolutionarily
determined patterns of allelic association between disease mutations and closely linked genetic
markers are used to narrow down the actual susceptibility gene. Methods combining tests of
linkage and allelic association to do both linkage and fine mapping in the same family sample
have been popular because they are immune to population stratification effects (Sharp,
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McQuillin, & Gurling, 2009). Many studies have been performed using these techniques to
identify genes associated with ADHD. The first systematic genome-wide linkage scan for loci
influencing ADHD identified chromosomal regions on 2q24, 5p12, 10q26, 12p13, 12q23, and
16p as possibly harboring genes increasing susceptibility of ADHD (Fisher et al., 2002). A
second genome-wide linkage study confirmed linkage to chromosome 16p13 (Smalley et al.,
2002). A recent meta-analysis of seven ADHD linkage studies (Arcos-Burgos et al., 2004;
Asherson et al., 2008; Bakker et al., 2003; Faraone et al., 2008; Hebebrand et al., 2006; Ogdie et
al., 2003; Romanos et al., 2008) confirms genome-wide significance for a region on chromosome
16, between 16q21–16q24, that is linked to ADHD (Zhou et al., 2008). Using this compellation
of multiple studies, 10 regions on chromosomes 5, 6, 7, 8, 9, 15, 16, and 17 with evidence for
linkage with ADHD were identified (Zhou et al., 2008). Thus, many studies have provided
evidence supporting the idea that ADHD has genetic components.
Since ADHD is believed to be inherited there have been studies done with twins to
determine heritability. In these studies, which varied in their methods and definitions of ADHD,
the mean heritability for ADHD was found to be 77% (Biederman, 2005). Other studies point to
the possibility that maternal smoking and alcohol exposure during pregnancy, low birth weight
and psychological adversity are independent, non-maternally heritable risk factors (Spencer et al.,
2007). ADHD is thought to be caused by catecholamine dysfunction (Gillberg, 2001) in brain
regions involved with attention and reward, including the nucleus accumbens (Podet et al., 2010;
Russell, 2000) and striatum (Krause et al., 2003), so a current theory of the cause of ADHD
posits that risk factors, combined with genetic linkages, could lead to catecholamine dysfunction.
Since catecholamine dysfunction is hypothesized to play a role in ADHD, molecular
genetic studies have been performed to look at gene mutations potentially leading to ADHD.
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Cook et al.’s study (1995) demonstrated a relationship between ADHD and the 480-bp allele of
the dopamine transporter gene using a family-based association study. Research regarding the
DRD4 gene has also yielded significant results suggesting its involvement in ADHD. LaHoste et
al. (1996) observed that the DRD4 7-repeat allele has functional implications that are relevant for
ADHD. This variant of DRD4 mediates a blunted response to dopamine, and the distribution of
DRD4 mRNA in the brain suggests it plays a role in cognitive and emotional functioning. The
study also involved a population study and found higher rates of the 7-repeat allele among
ADHD children compared to control children carefully matched for ethnicity and gender.
Furthermore, while the etiology of the disorder is unknown, it is likely that non-genetic factors
interact with genetic predisposition, leading to neurochemical changes that, unless compensated
for neurochemically or behaviourally, present as ADHD (Faraone & Doyle, 2000; Sagvolden et
al., 2005; Muller et al., 2008).

1.4 Neurophysiology
Catecholamines are a class of organic compounds that have a catechol group and a sidechain amine. The most abundant catecholamines in the body are epinephrine, norepinephrine,
and dopamine, all of which are produced from phenylalanine and tyrosine. Studies have
demonstrated that patients with ADHD have depleted levels of dopamine and norepinephrine in
the frontal regions of the brain, particularly the prefrontal cortex and associated subcortical
structures and circuits, and these depleted levels are thought to be the result of dysfunction of
their respective transporter systems (Prince, 2008).
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1.4.1 Dopamine
Neurotransmission is an essential component of brain functioning. The level and function
of particular neurotransmitters are controlled by a variety of factors. One of the most common
and widely studied neurotransmitters is dopamine. Dopamine is synthesized by the enzyme
tyrosine hydroxylase (TH), which catalyzes the conversion of tyrosine to
dihydroxyphenylalanine (DOPA). After this process dopa decarboxylase (DDC) catalyzes the
conversion of DOPA to dopamine. Once produced and released into the synaptic cleft, dopamine
interacts with five major dopamine receptors and is removed from the synaptic cleft by a specific
dopamine transporter. Dopamine has a variety of projections and plays a major role in many
processes. For example, dopaminergic projections from the midbrain ventral tegmental area
(VTA) to the striatal and prefrontal cortical areas play a major role in motor control, attention,
and impulsivity (Li et al., 2007). Therefore, mutations in genes involved in translation, synthesis,
signaling or metabolism of dopamine, could affect the efficiency of this neurotransmission
pathway causing significant deficits in functioning and possibly disorders, such as ADHD.
Many studies have investigated the potential role of dopamine system genes with ADHD.
Two genes, DAT1 and DRD4, coding for a dopamine transporter (DAT1) and dopamine receptor
four (DRD4) have been reported to be associated with ADHD in different samples. The
association of these dopamine genes with ADHD suggests that the two attentional networks that
include brain regions rich in dopamine receptors, such as the basal ganglia and
anterior cingulate gyrus, may be involved in the attentional deficit component of ADHD
(Swanson et al., 2000).
Similarly, depletion of dopamine in the brain is associated with impairment of not only
motor but also of memory and cognitive function, which are intimately related to the
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hippocampus. Many physiological, pharmacological, and behavioral studies support the idea that
dopamine acts as a neurotransmitter in the hippocampus and modulates the activities of
hippocampal neurons (Yokoyama, Okamura, & Ibata, 1995). Therefore, the connection between
dopamine and learning and memory has been investigated. Studies have shown that
mesolimbocortical dopamine plays a role in learning and memory, and many dopamine D1, D2,
and D3 receptors are expressed in the hippocampus (Schwegler et al., 1981). The interaction
between each dopamine receptor type with respect to learning and memory has also been
investigated. In one study, Sigala, Missale, and Spano (1997) suggested that the effects of
dopamine on memory consolidation are the result of a balance between dopamine D2 receptormediated facilitation and dopamine D3 receptor-mediated inhibition.

1.4.1 Norepinephrine
Another common neurotransmitter that is involved in a variety of brain functioning is
norepinphrine or noradrenaline, and areas of the body that produce or are affected by
norepinephrine are described as noradrenergic. Executive function and noradrenergic activation
is known to profoundly affect the performance of attention, especially the maintenance of arousal,
and the ability to sustain attention on a subject. Similarly, attention depends on adequate
modulation by catecholamine neurotransmitters of prefrontal, cingulate and parietal cortices,
thalamus, striatum, and hippocampus, and these brain networks all have a high distribution of
noradrenergic neurons. Arnsten (1999) and colleagues have evidence supporting that adequate
levels of noradrenaline are necessary for optimal function of the prefrontal cortex, that very high
levels of catecholamine release disrupt cognitive functions of the prefrontal cortex, and that these
alterations can improve with α2-adrenergic agonists.
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There is increasing evidence that the locus-coeruleus norepinephrine (LC–NE) system
plays a role in the pathophysiology of ADHD. The LC is a small nucleus in the pons of the
brainstem, composed of noradrenergic neurons that project widely throughout the neocortex. It is
the sole source of norepinephrine in the hippocampus, and several genetic studies have suggested
associations between ADHD and various genes involved in norephinephrine transmission. Some
of the candidate genes thought to be involved in this association are genes encoding for the
enzyme dopamine beta-hydroxylase, which is responsible for converting dopamine to
norephinephrine, the norepinephrine adrenoceptors, and the norepinephrine transporter (NET).
Also, some treatments that have been proven effective in ADHD patients, such as atomoxetine, a
NET blocker, and guanfacine and clonidine, α2-adrenoceptor agonists, work on norephinephrine
transmission, which presents another piece of evidence supporting norephinephrine’s role in
ADHD (Sterley, Howells, & Russell, 2013). Despite their chemical differences, the various
medications with documented therapeutic benefits on ADHD symptoms share a common
noradrenergic/dopaminergic activity.

1.5 Neuroanatomy of ADHD
With the improvements in neuroimaging, the knowledge of the details of brain anatomy
in children with ADHD has been greatly increased. Using structural brain MRI, evidence of
structural abnormalities in children with ADHD has been gathered. Initially, the focus of
structural MRIs concerning ADHD was on the frontostriatal circuitry in children with ADHD.
Studies focusing on this region pinpointed significant differences in this brain circuitry. As
researchers have broadened their scope, other brain regions have been witnessed to exhibit
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morphological alterations in areas such as the cerebellum and temporoparietal lobes, basal
ganglia, and corpus callosum (Cortese, 2012).
A recent voxel-based morphometric (VBM) meta-analysis found that individuals with
ADHD had a significant global reduction in grey matter volumes, most prominently in the right
lentiform nucleus and extending to the caudate nucleus (Nakao, et al., 2011). Another recent
VBM study in young adults found that individuals with ADHD had less grey matter in the right
inferior frontal gyrus, which correlated with poorer outcomes in measures of processing speed,
response inhibition and response variability, compared with matched controls (Depue, et al.,
2010). Although there is a significant global reduction of grey matter in individuals with ADHD
it has been highlighted that the morphological alterations found in children with ADHD are
unlikely to be leading to the behavioral symptoms. This is because unaffected first-degree
relatives also exhibit similar changes in cortical grey and white matter (Durston et al., 2004).
Furthermore, the imagining studies point to the idea that there is dysfunction in the
fronto-subcortical pathways. These findings can help explain why stimulants have a positive
effect on the symptoms of ADHD. The areas implicated are high in catecholamines, which are
involved in the mechanism of action of stimulant medications (Biederman, 2005). Stimulants
work by inhibiting the dopamine transporter and blocking dopamine and norepinephrine
reuptake in to the presynaptic neuron. This causes an increase in the monoamine concentration in
the extraneuronal space (Elia et al, 1990). In order for a drug to improve ADHD symptoms, the
drug needs to cause changes in the dopaminergic and nonadrenergic function. Those changes in
dopaminergic and nonadrenergic function lead to the theory that through the dopaminergic
and/or the noradrenergic pathways the stimulants increase the inhibitory influences of frontal
cortical activity on subcortical structures (Zametkin & Rapoport, 1987). There are three
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subcortical structures that are implicated by the imaging studies: caudate, putamen, and globus
pallidus. These structures are part of the neural circuitry, underlying motor control, executive
functions, inhibition of behavior, and modulation of reward pathways (Biederman, 2005).
According to Pontius (1973) the caudate nucleus and its associated circuits have been found to
be implicated in ADHD. The caudate nucleus and the putamen are the entry points of the basal
ganglia and many studies have documented abnormalities of both structures in ADHD (Krain &
Castellanos, 2006). The caudate is generally asymmetrical with the left volume being larger than
the right in normal functioning children. Children with ADHD have a reduced volume of the left
caudate making the caudate more symmetrical (Krain & Castellanos, 2006). In some studies of
the putamen, the volume of this area was not significantly different in those with ADHD or those
without ADHD. However, there has been functional imaging studies that show a decreased blood
flow to the putamen area of boys with ADHD compared to the control group without ADHD
(Teicher et al, 2000). The globus pallidus receives input from the caudate and putamen and was
found to be significantly smaller in children with ADHD compared to their control counterparts
(Krain & Castellanos, 2006).
In addition, the cerebellum has also been examined in children with ADHD. The
cerebellum is involved in coordination of motor movements and is also involved in non-motor
functions such as timing and attention shifting through connections in frontal regions (Allen et al,
1997). Studies have shown that the vernal volume is smaller in children with ADHD and there is
a decrease in size of the posterior inferior lobe of the cerebellum (lobes VIII-X) of those with
ADHD as compared to the controls (Krain & Castellanos, 2006). Other imaging studies have
been done on the correlation of regional brain volumes and the neurophysiological functioning in
children with ADHD. These studies have found that larger volumes predicted poorer
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performance on the Conners’ Continuous Performance Test (CPT), variability, and reaction time
standard error scores as compared to their healthy controls (Hill et al, 2003). The conclusions of
these results are that the right dorsolateral region might be dysfunctional in ADHD individuals
and that the more tissue in a region the greater the disruption in attention (Krain & Castellanos,
2006).
In addition to the observed differences in the volume of specific brain areas, there is also
evidence that fibers that connect these areas are affected. The corpus callosum connects the
homotypic regions of the two cerebral hemispheres. Studies have shown that there are volume
differences in those with ADHD, and that there are also volume differences in the number of
cortical neurons in the corpus callosum of individuals with ADHD. This change in volume is
believed to degrade communication between the hemispheres, which is believed to be
responsible for some of the cognitive and behavioral symptoms of ADHD (Spencer, 2007).
There seems to be ample evidence to show that ADHD is involved in the decreased brain volume
compared to controls. The decreased brain volume is nonprogressive and likely caused by
genetic factors, as well as, environmental factors in the early developmental ages (Krain &
Castellanos, 2006).

1.6 Pharmacotherapy of ADHD
For the last 50 years the standard ADHD treatment has been catecholaminergic
psychostimulants. In 2004 a multimodial treatment study for ADHD was conducted that showed
that behavioral therapy was ineffective in the treatment of ADHD but methylphenidate was
highly effective in managing the disorder (MTAS Cooperative Group, 2004). Since this study
pharmacotherapy has been the primary choice of treatment. The drugs proven to be the most
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effective for the treatment of ADHD are amphetamine, atomoxetine and methylphenidate.
Amphetamines are monoamine releasing agents. Methylphenidates are psychostimulant
catecholamine reuptake inhibitors. Atomoxetine is a reuptake inhibitor. Atomoxetine is a
nonstimulant drug because it acts as a potent inhibitor of the presynaptic norepinephrine
transporter, which causes more norepinehrine to be available to increase attention and control
hyperactivity and impulsivity for the treatment of ADHD (Kratochvil et al., 2002). This nonstimulant is used for patients who react poorly or cannot tolerate stimulant medication. In
addition, atomoxetine may be used if there is a concern with drug misuse (Michelson et al, 2003).
The research shows that this drug therapy is more effective in adults than children. The theory
behind this is that children tend to have more hyperactive signs and symptoms than adults. The
research shows that both the inattentive and hyperactive or impulsive symptom clusters
responded to the atomoxetine but the magnitude of change was less for children. The theory
behind the mechanism of atomoxetine is that the compound is very specific for the
norepinephrine transporter and does not seem to be active at the dopaminergic transporters
(Michelson et al, 2003). In rat studies atomoxetine increases dopamine in the prefrontal cortex
but not in the nucleus accumbens or striatum (Bymaster et al, 2002) which may account for its
efficacy and lack of abuse potential (Heil et al, 2002).
Methylphenidate (MPH) is the most effective psychostimulant in use for the treatment of
ADHD. It is a catecholamine reuptake inhibitor with stronger dopamine agonist effects in the
basal ganglia and both dopamine and noradrenalin agonist effects in the cortical brain regions
(Arnsten, 2006). The research shows that patients with ADHD have elevated levels of brain
activation. Research suggests that MPH normalizes effects of the brain activation in the regional
inter-connectivity pathways and has a greater efficacy on the inattentive problems and less for
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impulsivity problems (Rubia, 2009). In the Rubia 2009 study, children with ADHD displayed
inactivation of the cerebellum, precuneous, posterior singulate, premotor, inferior frontal and
parietal regions compared to controls. MPH reduced the fronto-stratial deficits and normalized
the dysfunction in the right and left superior temporal and inferior parietal cortices (Rubia, 2009).
MPH is effective in improving attention performance by a very complex regulatory effect of the
dysfunctional brain networks by downregulating hypersensitive paralimbic reward processing
regions while upregulating hyposensitive and underconnected task-relevant fronto-stratiocerebello-aprietal attention networks (Rubia, 2009).
Amphetamines are monoamine releasing agents that work both inside and outside the
presynaptic neurons. The drug is actively transported in to the presynaptic terminal where they
displace catecholamines from the vesicle storage pools (Sulzer & Rayport, 1990). Two of
amphetamine’s main targets are cell membrane and vesicular monoamine transporters, such as
the neuronal dopamine transporter and the vesicular monoamine transporter-2. The molecular
mechanism of amphetamine causes monoamine, particularly dopamine, release, and this
monoamine release is caused by amphetamine-induced exchange diffusion, reverse transport,
and channel-like transport phenomena as well as the weak base properties of amphetamine. Also,
amphetamine analogs may affect monoamine transporters through phosphorylation, transporter
trafficking, and the production of reactive oxygen and nitrogen species (Fleckenstein et al., 2007).
Treatment of ADHD with amphetamine is especially popular and appealing because it has been
shown to be a viable long-term treatment. In children with ADHD, once-daily mixed
amphetamine salts such as Adderall were well tolerated, and the children showed significant
behavioral improvements that were consistently maintained during 24 months of treatment
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(Mcgough et al., 2005). The efficacy of stimulant agents suggests that the neurotransmitter
abnormalities seen in ADHD are primarily catecholaminergic in origin.

1.7 Animal Models
Animal models are widely used throughout most fields of neuroscience research,
particularly in the examination of psychological disorders. Several criteria need to be met before
an animal model can be considered to be a true and effective model of a psychiatric disorder. An
animal model for ADHD should include face validity, construct validity, and predictive validity
(Davids et al, 2003). Face validity means that the model must mimic fundamental behavioral
deficits found in ADHD patients. Construct validity means that the model must conform to a
theoretical rationale. The predictive validity means that one must be able to predict the unknown
aspects of ADHD in areas like genetics, neurobiology and therapies (Davids et al, 2003). The use
of an animal model for a disorder has advantages: data may be easier to interpret than extensive
clinical cases, animals are less heterogeneous, and the environment can be controlled. There have
been many animal models of ADHD such as rats reared in social isolation, rats exposed to
environmental pollutants such as lead or PCBs, rats that have undergone neurotoxic brain lesions,
and rats that have undergone hippocampal X-irradiation. The genetic models used for ADHD
include the Spontaneously Hypertensive Rat, Naples High/Low Excitability Rat, and Knock Out
Mice with disrupted DAT gene, and another category of animals models of ADHD are animals
prepared by brain lesioning or exposure to neurotoxins usually early in development (Sagvolden,
2000).
The SHR rat is a rat strain that has genetically inherited hypertension that was developed
in Japan by inbreeding rats of the Wistar-Kyoto (WKY) strain (Okamoto, 1963). This rat was
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bred for studying hypertension, but it was later found that the rat had unexpectedly high
spontaneous motor activity and it was suggested that the strain would be a good animal model
for the study of ADHD (Moser et al, 1988). The SHR rat exhibits characteristics that are
common to patients with ADHD such as motor hyperactivity in a novel environment, excessive
conditioned responses under a fixed interval, and difficulty in acquiring operant tasks. These
abnormalities correlate to clinical features of hyperactivity, impulsivity, and learning deficit
(Mook, 1993). The SHR rat is also more sensitive to immediate behavior reinforcement and less
sensitive to delayed reinforcement than the control rat WKY that is not hypertensive (Sagvolden,
1992). Like children with ADHD, the SHR have also been found to be sensitive to immediate
behavioral reinforcement and responsive to stimulant medication. Altered dopaminergic and
noradrenergic neurotransmission has also been observed in the SHR as a result of the mutated
genes associated with these neurotransmission systems, strongly implicating these systems in the
etiology of ADHD. Further sequencing of dopaminergic loci identified polymorphisms in the
dopamine transporter gene, the DAT1 gene (Mill, 2007). Therefore, it is possible that DNA
sequence changes in the DAT1 gene account for some of the behavioral inconsistencies observed
between the SHR and WKY strains, which is also consistent with evidence showing that SHR
strains exhibit elevated DAT expression in mesocortical projections (Viggiano et al., 2002;
Watanabe et al., 1997).
Li et al. (2007), demonstrated that the SHR have decreased turnover of dopamine in the
VTA, striatum, and frontal cortex compared to WKY. Prior studies examining dopamine
function in the SHR and WKY rat brains have shown lower dopamine levels in the striatum in
the SHR (Linthorst et al., 1991). Striatal uptake of dopamine in the SHR has also been reported
to be slower (Leo et al., 2003) compared to the WKY, and a higher concentration of dopamine
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transporters in the striatum of the SHR was found (Watanabe et al., 1997). It has been shown that
extracellular dopamine levels in the nucleus accumbens are higher in the SHR compared to the
WKY (Carboni et al., 2003). Thus, there are several differences in the neurotransmission of
dopamine, primarily related to release and uptake, between the WKY and SHR. Since dopamine
neurotransmission is related to ADHD, the differences in this neurotransmission system directly
relate to the ADHD symptoms in the SHR. Interestingly, this alteration in dopaminergic
neurotransmission translates to afflicted humans, since individuals with ADHD have been shown
to exhibit increased dopamine transporter density in the brain (Dougherty et al., 1999). Similarly,
the norepinehrine system of SHR is over-responsive to acute challenges compared to WKY and
other control rat strains (Sagvolden, 2000; Russell et al., 2005)

1.8 Hippocampus
The hippocampus includes the pyramidal cell fields of the hippocampus proper (CA1CA2) together with the hilar and granular cells in the dentate gyrus (Jarrard, 1993). The
hippocampus processes cortical information from the entorhinal cortex and important subcortical
projections by way of the fimbria-fornix (Jarrard, 1993). One of the best understood of the
cortically related circuits consists of major projections from the entorhinal cortex through the
perforant path to dentate gyrus, through the hippocampus and to the subiculum (Amaral & Witter,
1989). The second major set of cortical related connections is the direct projection from
entorhinal cortex that bypasses dentate gyrus and terminates in the subiculum and the CA1 cell
field (Jarrard, 1993). The intricate nature of the hippocampus makes it especially difficult to
pinpoint its exact function. There have been theories over the years that differ in the fact that
some believe that the hippocampus is primarily involved in the processing and memory of spatial
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information and others believe that the hippocampus is more involved in the more abstract
learning and memory processes (Jarrard, 1993). One thing that all theorists agree on is as far as
the hippocampus function goes spatial information processing occurs there.
As mentioned, it is well established that the integrity of hippocampal formation is
essential for spatial learning. In order to further examine the hippocampus’s role in learning and
memory, the Morris Water Maze (MWM) has often been utilized. The MWM is as an
instrument with particular sensitivity to the effects of hippocampal lesions in rats. Interestingly,
from research conducted in the MWM, the spatial learning impairment of hippocampus-lesioned
rats has shown to be related to the volume of damaged hippocampal tissue. Also, dorsal
hippocampal lesions were reported to have more profound effects than ventral hippocampal
lesions. Similarly, evidence indicates that the hippocampus is necessary for acquisition and
retrieval of spatial information as well as for consolidation and storage of spatial information
(D’Hooge & Deyn, 2001). Riedel et al.’s study demonstrated that reversible hippocampal
inactivation using a water-soluble AMPA/kainate antagonist seriously impairs MWM
performance in rats. Therefore, since the MWM is a task testing learning and memory,
hippocampal activation is essential for normal memory and learning functioning.

1.9 Radial Arm Maze
Since its design 25 years ago (Olton & Samuelson, 1976), the eight-arm radial maze has
become very popular and is now widely used to assess spatial memory in rodents. The radial
arm maze (RAM) has become a common method for assessing spatial memory in rodents. It has
proven to be quite useful in the investigation of the effects of a variety of pharmacological
manipulations on spatial memory. The cholinergic system has been found to be crucial for
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accurate RAM performance (Levin, 1988). The radial arm maze has been increasingly utilized
to examine the psychological and neurobiological substrates of cognitive function (Walsh &
Crobak, 1987). In its most basic form the task involves baiting several arms and assessing if the
rats visit unbaited arms, commit reference memory errors, or if rats revisit baited arms after
retrieving the reward and commit working memory errors. This procedure allows for the
quantifiable measure of working and reference memory and separation of working memory from
reference memory (Kay, Harper, & Hunt, 2010).
The radial arm maze (RAM) is considered to be one of the most sensitive methods for
evaluating spatial learning and memory in rodents. It has been suggested that animals perform it
successfully by utilizing a spatial map formed at the start of the maze solution and by using
extramaze cues. Studies looking at the hippocampus and learning and memory have been done
using a radial maze that permits studying the acquisition of two kinds of information, spatial
versus intramaze cues, and two different memory functions, reference memory versus working
memory. In the spatial version of the task the eight arms of the radial maze were similar, but
differed in their spatial location in the room. There were extramaze cues that remained constant
over trials including arrangement of cages, the door, shelves, lighting, location of experimenter,
etc. For each animal the same four out of eight arms were consistently baited over trials. In the
intramaze cue task different textured floor inserts were moved among the eight arms in a random
order, and the rat was rewarded after choosing the same four cues independent of spatial location.
Another difference between the tasks was that in the extramaze cue task the normal room
lighting was used thus making the extramaze cues readily visible, and in the intramaze cue task a
single light bulb with a reflector directly over the maze served to minimize room cues. Correct
performance in the extramaze cue task requires the use of distal, spatial cues, and that proximal
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cues are important for correct performance in the intramaze cue task. Furthermore, the intramaze
and extramaze cue tasks appear to be of equal difficulty for normal rats since the tasks are
learned at the same rate. Because only four out of eight arms were baited, reference memory and
working memory could be assessed. Reference memory errors were operationally defined as
choices of arms that were never baited, and working memory errors were repeated entries into
arms that were correct but had already been visited on that trial (Jarrad, 1993). The limited
baiting procedure provides a test of the working memory theory proposed by Olton et al. (1979),
since the theory would predict that rats with hippocampal damage would be impaired in working
memory, but not reference memory, on both the extramaze and intramaze cue versions of the
radial maze. In contrast, the spatial mapping theory of O'Keefe and Nadel (1978) would predict
that without a hippocampus the animals would be impaired on the extramaze task but not the
intramaze task.
The results of these studies yielded very interesting results. Rats with the hippocampus
removed showed significant impairment on the intramaze cue task, and they made both reference
and working memory errors. Similarly, these rats showed difficulty with the extramaze cue task;
however, only working memory errors were made. Therefore, these results supported that the
hippocampus plays a role in spatial mapping and working memory. The rats with hippocampal
lesions committed reference memory errors in the intramaze cue tasks, and with training these
rats learned to make only a few working memory errors. Thus, this evidence also suggests that
the hippocampus plays a general role in memory, and it is the memory process that is affected in
hippocampal rats, not the type of information that is being learned (Jarrad, 1993). Also, the
RAM has been used to examine and show the deficits of spatial learning and working memory in
spontaneously hypertensive rats (Nakamura-Palacios, Caldas, Fiorini, Chagas, Chagas, &
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Vasquez, 1996). Another study examining the effects of amphetamine on RAM performance
have shown that the activation of the dopaminergic system by amphetamine does not compensate
for the alteration of the cholinergic activity inducing amnesia; however, the results of the study
suggest that amphetamine has an improving effect on locomotor activity but little to no effect on
the memory measures (Ennaceur, 1994). Thus, the RAM is a cognitive task that has been proven
very useful in the investigation of the neuronal systems and neurotransmitters involved in
learning and memory and the influence of drugs on them.

1.10 c-Fos
In the mammalian nervous system, induction of an immediate early gene (IEG) is one of
the first signs of a genomic response to a stimulus (Sheng & Greenberg, 1990). The best known
of the IEGs are the proto-oncogene transcription factors, and a prime example of a protooncogene transcription factor is c-Fos (Beckmann & Wilce, 1997). IEG induction can be
demonstrated in cells or regions of tissue sections by immunohistochemistry (IHC), which show
protein expression in precise locations. Microscopic evaluation of c-Fos expression has been
extensively studied in the brain and has become widely regarded as a mapping tool for sites of
cell activation (Herrera & Robertson, 1996; Hoffman & Lyo, 2002; Kaczmarek & Robertson,
2002). Many stimuli induce genomic responses. One of the more common stimuli used are
pharmacological stimuli. Acute injection of a drug elicits responses, including induction or
downregulation of an IEG in the brain (Herrera & Robertson 1996). Drugs that increase
dopamine release and favor transmission through D1 receptors, such as amphetamine and
cocaine, are effective inducers of c-Fos. Therefore, evidence has shown that the psychostimulant
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amphetamine activated the most brain regions, including the most cortical regions (Sumner,
2004).
c-Fos expression is also induced after some forms of learning. It has been shown that
increased c-fos expression is linked to increased neural activity, such as learning and memory.
Thus, learning and memory formation is also associated with c-Fos expression, and the greater
the memory loading, the greater the c-Fos expression expected. Since learning and memory is a
major concern in everyday life, learning and memory and more specifically the hippocampal
expression pattern of Fos has been studied. One study evaluated the Fos expression in rats
exposed to one of two different memory tasks in an eight-arm radial maze. The radial arm maze
(RAM) can be used to assess working and reference memory simultaneously in the fixed position
of reward task (FPRT). The FPRT consists of baiting half of the arms and having their positions
fixed throughout the training trails. Another task can be used to assess memory called the
variable position of reward task (VPRT), in which four out of eight arms were baited, but the
positions were varied in every training trial. In the VPRT, the rats learned to choose all arms
without any discrimination between baited and non-baited arms and the memory retention was
time-dependent. After comparing Fos immunohistochemistry between rats that completed FPRT
and the rats that completed VPRT, the results revealed that there was more c-Fos expression in
the hippocampus in the VPRT than the FPRT. This result demonstrated that the hippocampus
may play a more important role in the acquisition of memory because acquisition is known to be
more involved in the VPRT than in the FPRT. Thus the mapping of c-Fos expression is a
valuable tool in learning about brain regions associated with different stimuli (He, Yamada,
Nakajima, Kamei, & Nabeshima, 2002).
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1.11 Experimental Goals and Objectives
The diagnosis of childhood ADHD is becoming increasingly prevalent in the United
States, and therefore, the prescription of psychostimulants is also becoming more prevalent.
Since many children have access to psychotimulants, the abuse of these prescribed
psychostimulants, especially Adderall, is becoming very popular in places where increased focus
is desired, such as college campuses. The mechanism of action of psychostimulants to produce
beneficial effects in individuals with ADHD and what effect these drugs may have in individuals
without ADHD is not well known. The cognitive effects of chronic use of low dose
psychostimulant treatment on individuals with and without ADHD are also not well understood.
The current study is aimed to examine the effects of exposure to chronic, low dose
amphetamine treatments on an ADHD rat model and age/strain matched controls on learning and
memory and the underlying neurobiological relationship between the drug conditions and animal
models. Understanding this relationship between chronic, low dose amphetamine administration,
cFos expression, and learning and memory could have immense practical and theoretical
implications in ADHD research and it could shed light on biological causes of the effects of
amphetamine on learning and memory.
In order to investigate this relationship, the present study was focused on the SHR model,
a validated rat model of ADHD. Using the behavioral results of the SHR animals compared to
the age/strain matched control animals the effects of amphetamine on learning and memory in
both the age/strain matched control and SHR animals can be assessed. The
immunohistochemical analysis of cFos expresson will also allow for a histological analysis of
the effects of amphetamine in the hippocampus, a major brain region associated with learning
and memory, in the two animal groups.
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1.12 Hypotheses
Overall it is hypothesized that chronic, low dose amphetamine administration will
enhance RAM performance in both the SHR animals and their age/strain matched controls.
More specifically, SHR animals and their age/strain controls given chronic, low dose
amphetamine administration are expected to commit fewer reference and working memory errors
than animals receiving saline administration throughout the course of the study. Also, SHR
animals and their age/strain controls given chronic, low dose amphetamine administration are
expected to complete the maze faster than animals receiving saline administration.
It is also hypothesized that the age/strain matched control animals with saline
administration would perform better on learning and memory tasks than SHR animals with saline
administration. Thus, the age/strain matched control animals given saline administration are
expected to commit fewer reference and working memory errors than SHR animals receiving
saline administration throughout the course of the study. Similarly, the age/strain matched
control animals given saline administration are expected to complete the maze faster than SHR
animals receiving saline administration throughout the course of the study.
In terms of immunohistochemistry, it is hypothesized that the greatest hippocampal c-Fos
expression will be seen in age/strain matched control with chronic, low dose amphetamine
administration. It is also hypothesized that age/strain matched controls receiving saline
administration will have greater c-Fos expression than SHR animals receiving saline
administration. Additionally, it is hypothesized that age/strain matched controls receiving
amphetamine administration will have greater c-Fos expression than age/strain matched controls
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receiving saline administration and that SHR animals receiving amphetamine administration will
have greater c-Fos expression than SHR animals receiving saline administration.
Method
2.1 Animals and Environment
Fourteen male Wistar-Kyoto rats and sixteen Wistar-Kyoto SHRs were obtained from
Charles River Labs and all weighed between 270-375 grams during the time of experimentation.
The rats were housed in pairs and kept in the Connecticut College animal facility where they
were maintained under standard temperature and humidity conditions. The rats were kept on a
12-hour light dark cycle and had access to food for one hour daily during experimentation and
unlimited access to water throughout the experiment. All experimental procedures were in
agreement with the NIH Guide for Care and Use of Laboratory Animals (National Research
Council of the National Academies, 2011). This experiment was approved by the Connecticut
College Institutional Animal Care and Use Committee (IACUC).
2.2 Drugs and Drug Administration
The stimulant D-amphetamine (Sigma-Aldrich) was dissolved in sterile saline (0.9%
NaCl) and administered intraperitoneally (i.p.) at 1 mg/kg in a volume of 1mL/kg.
2.2 Radial Arm Maze
The RAM consisted of eight arms (48 cm × 12 cm) radiating from a central area (32 cm
in a diameter). Before training, rats were shaped to run to the ends of the radiating arms.
Chocolate flavored rice cereal was used as a food reward (bait). In order for the animals to be
motivated to complete the maze, they were food deprived one day prior to the beginning of
trained. The animals were allowed to eat for one hour per day after the completion of the RAM.
The baits were initially available throughout the maze, but were gradually restricted to the end of
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the arms. Following this shaping period, rats were trained by performing one trial per day. Four
arms of the maze were baited with a single reward, while the remaining four arms were left
unbaited. Baited arms varied from animal to animal but remained the same for each animal
throughout the experiment. Each trial continued until all four baits had been consumed or until
10 min had elapsed. The number of reference memory errors (entering an arm that was not
baited), number of working memory errors (re-entering a bait-containing arm where the bait had
been consumed), and total latency to complete the maze were recorded.
In this study, rats received a single injection of amphetamine or saline (1 mg/kg, i.p.) 10
minutes prior to maze exposure daily for 23 days. The rats were sacrificed 30 minutes after they
satisfied the following criteria: either committing zero working memory errors and one or less
reference memory errors for three consecutive days or the completion of their 23 training day.

2.3 Immunohistochemistry
Tissue Preparation.
On day 23, all animals were euthanized by exposure to carbon dioxide within fifteen
minutes of testing. Each animal was transcardially perfused with physiological saline (400-500
ml), followed by 4% paraformaldehyde solution (400-500 mL). The brain of each animal was
removed and post-fixed in 4% paraformaldehyde overnight before being transferred to 30%
sucrose solution for storage until sectioning. Sections were obtained in a -20°C cryostat and were
stored at 4°C in cryoprotectant. Tissue sections (40 µm) were taken from the hippocampus in
each rat brain. For each brain, five to six slices of tissue were obtained and stored for
examination of c-Fos expression.
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Immunohistochemistry.
Immunohistochemistry was conducted to examine levels of c-Fos in the hippocampus of
each rat. The staining method utilized was the avidin-biotin-horseradish peroxidase (ABC)
method. First, the tissue was washed three times, for ten minutes each, in 0.01M Phosphate
Buffer Saline (PBS) before being incubated for 24 hours with a 1:8000 Fos primary antibody
dilution. This dilution was made using 6.3 µl of rabbit anti-Fos polyclonal IgG (Santa Cruz) and
50 mL of a blocking solution that contained 98.75 mL 0.01M PBS, 1 mL 1% normal goat serum,
1g 1% bovine serum albumin and 0.25 mL 30% Titron-X100. Following incubation, the tissue
was washed three times in 0.01M PBS for ten minutes each and sections were incubated in 1 mL
biotinylated goat anti- rabbit polyclongal IgG antibody (Jackson Laboratories) diluted 1:200 in
50 mL of the blocking solution for two hours. A third series of PBS tissue washes were
conducted, and sections were incubated for one hour with avidin-biotin-horseradish peroxidase
complexes (ABC kit by Vector Laboratories) in 50 mL 0.01M PBS. After this incubation period,
sections were washed three times for ten minutes each with 0.1M Phosphate Buffer (PB). For
ten minutes sections were placed in a solution composed of glucose oxidase, cobalt, chloride,
nickel ammonium sulfate, ammonium chloride and diaminobenzidine (DAB) in 50 mL of 0.1M
PB. The presence of glucose started the peroxidase reaction, which lasted approximately fifteen
minutes. The reaction was monitored and terminated when the appropriate color was reached by
placing sections into 0.01M PBS. The tissue was washed three more times with 0.01M PBS for
ten minutes each, and then tissue samples were then stored in 0.01M PBS solution until
mounting (Grahn, et al, 1999).
Slide Preparation.
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Representative slices of each brain were mounted onto pre-treated slides, and underwent
a dehydration sequence before cover slips were glued onto each slide. This dehydration sequence
consisted of placing each slide in 50% ethanol for 2 minutes, 70% ethanol for 2 minutes, 95%
ethanol for 10 minutes, 100% ethanol for 2 minutes, and then Neoclear for a minimum of 5
minutes. Once slides were fully dehydrated they were coverslipped using mounting glue and
underwent microscopic image analysis for examination of c-Fos expression.
2.4 Statistical Analysis
The analysis of data was conducted independently for each experimental group as well as
each behavioral measure (reference memory errors, working memory errors, and maze latency).
Statistical analyses (one-way analysis of variance) were conducted to examine the relationship
between drug and behavioral parameters using the Statistical Package for the Social Sciences
(SPSS).

Results
3.1 Radial Arm Maze
To investigate the effect of amphetamine on Wistar-Kyoto rats and SHRs, three
parameters were examined for each drug condition: the time to maze completion, the frequency
of reference memory errors, and the frequency of working memory errors. Averages for each
variable were calculated for week 1 (days 2-8), week 2 (days 9-15) and week 3 (days 17-22) and
one-way ANOVAs were performed on the data for each week.
3.1a Time to maze completion. To examine if the time to maze completion differed
between control and SHR animals in each drug condition, a one-way ANOVA was performed
for each week of the experiment. In week one (days 2-8), significant main effects of drug and
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strain were observed between the Control/Amphetamine (M=81.18, SD=19.45) Control/Saline
(M=142.23, SD=48.10), SHR/Amphetamine (M=141.94, SD=22.13) and SHR/Saline groups
(M=62.42, SD=22.14), (F(3,31) = 4.482, p<0.01) (Figure 1). Post hoc multiple comparison tests
(Tukey’s HSD test) determined that the Control/Amphetamine group completed the maze
significantly faster than the Control/Saline group, and both SHR groups (Figure 1). In week two
(days 9-15), one-way ANOVA revealed a significant main effect between the
Control/Amphetamine (M=73.69, SD=15.34) Control/Saline (M=66.71, SD=15.23),
SHR/Amphetamine (M=99.01, SD=19.97) and SHR/Amphetamine groups (M=102.21,
SD=26.70), (F(3,31) = 6.450, p<0.01), and Tukey post hoc multiple comparison tests determined
that the Control/Amphetamine group completed the maze significantly faster than the
SHR/saline group and the Control/Saline group completed the maze significantly faster than both
SHR groups (Figure 1). In week three (days 16-22), one-way ANOVA revealed a significant
main effect between the Control/Amphetamine (M=106.44, SD=26.75) Control/Saline (M=55.85,
SD=12.14), SHR/Amphetamine (M=69.19, SD=23.99) and SHR/Amphetamine groups
(M=47.30, SD=8.29), (F(3,31) = 14.48, p<0.01) (Figure 1). Post hoc multiple comparison tests
(Tukey’s HSD test) determined that unlike in week one the Control/Saline group completed the
maze significantly faster than the Control/Amphetamine group, and again unlike in week one
both SHR groups completed the maze significantly faster than the Control/Amphetamine group
(Figure 2). In summary, amphetamine appeared to improve latency to complete the maze in
control animals during week one but with repeated administration amphetamine hindered maze
latency by week three. This effect was not observed in the SHR groups as no significant
differences in time to maze completion were observed between the SHR drug conditions during
any week (Figure 3).
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3.1b Reference Memory Errors. To examine if the frequency of reference memory errors
differed between control and SHR animals in each drug condition, a one-way ANOVA was
performed for each week of the experiment. In week one no main effect was observed between
conditions (F(3,31)=1.579, p>0.05), (Figure 4). In week two, a main effect of drug condition
was observed between Control/Amphetamine (M=4.76, SD=0.92) Control/Saline (M=2.65,
SD=0.62), SHR/Amphetamine (M=4.30, SD=0.88) and SHR/Amphetamine groups (M=4.46,
SD=1.01) (F(3,31) = 9.556, p<0.01). Post hoc multiple comparison determined that the
Control/Saline group committed significantly fewer reference memory errors than all the other
groups (Figure 4). In week three, a main effect of drug condition was observed
Control/Amphetamine (M=4.90, SD=1.20) Control/Saline (M=2.33, SD=0.57),
SHR/Amphetamine (M=4.00, SD=1.17) and SHR/Amphetamine groups (M=3.75, SD=0.81)
(F(3,31) = 10.19, p<0.01). Tukey post hoc multiple comparison tests determined that like in
week two the Control/Saline group committed significantly fewer reference memory errors than
all other groups (Figure 5). No significant differences in frequency of reference memory errors
were observed between the SHR drug conditions during any week (Figure 6).
3.1c Working Memory Errors. To examine if the frequency of working memory errors
differed between conditions, a one-way ANOVA was performed for each week of the
experiment. In week one no main effect was observed between conditions (F(3,31)=1.869,
p>0.05), (Figure 7). In week two, a main effect of behavioral condition was observed between
Control/Amphetamine (M=1.93, SD=0.85) Control/Saline (M=0.88, SD=0.43),
SHR/Amphetamine (M=2.59, SD=1.00) and SHR/Amphetamine groups (M=3.13, SD=1.13)
(F(3,31) = 9.486, p<0.01), and post hoc multiple comparison tests determined that the
Control/Saline group committed significantly fewer working memory errors than both SHR
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groups. In week three, a main effect was observed between the Control/Amphetamine (M=2.14,
SD=0.80) Control/Saline (M=0.46, SD=0.32) (Figure 8), SHR/Amphetamine (M=1.42,
SD=0.64) and SHR/Amphetamine groups (M=1.30, SD=0.44) (F(3,31) = 10.19, p<0.01). Post
hoc multiple comparison tests determined that the Control/Saline group committed significantly
fewer working memory errors than all other groups (Figure 7). No significant differences in
frequency of working memory were observed between the SHR drug conditions during any week
(Figure 9).

3.2 Immunohistochemistry
No c-Fos positive cells were detected after the immunohistochemical procedure;
therefore, no results were gathered.
Discussion
Results of this study do not support the theory that amphetamine would promote learning
and memory in both control rats and SHRs. Findings suggest that chronic amphetamine
treatments have hindering effects on learning and memory in control rats, and chronic
amphetamine treatments have no effect on learning and memory of SHRs compared to SHRs
receiving saline injections. When maze completion latency is used as a measure of learning and
memory, amphetamine appears to enhance maze performance during the first week of learning
and hinder learning during the third week. The results were consistent with the hypothesis that
control animals treated with saline would perform better on memory tasks than SHRs treated
with saline.

4.1 Radial Arm Maze
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Findings of the study were inconsistent with the hypotheses that amphetamine would
have beneficial effects on maze performance. Initially control animals receiving daily
amphetamine injections completed the maze significantly faster than control animals receiving
daily saline injections. However, by the third week of training control animals receiving daily
saline injections completed the maze faster than control animals receiving daily amphetamine
injections. Also, the control animals treated with saline showed a steady decrease in time to
maze completion over the course of training. Whereas, the control animals receiving
amphetamine treatments showed no decrease in time to maze completion throughout the study.
These results suggest that chronic amphetamine treatment in control animals hindered the
animals’ ability to learn the maze and quickly retrieve the food rewards. In the SHR animals,
throughout the entire experiment no significant differences in time to maze completion were seen
between the animals receiving daily amphetamine injections and animals receiving daily saline
injections. Both SHRs treated with saline and SHRs treated with amphetamine showed steady
decreases in time to maze completion throughout the course of the experiment. Therefore, unlike
in the control animals, chronic amphetamine treatments did not hinder time to maze completion
in SHRs.
The results of reference memory errors also showed inconsistencies from the hypotheses.
In week one no significant differences were observed in frequency of reference memory errors
between control animals receiving daily saline injections and control animals receiving daily
amphetamine injections. However, by week two of the experiment, control animals treated with
saline committed significantly fewer reference memory errors than control animals treated with
amphetamine. This trend continued through week three because control animals that received
daily saline injections again made significantly fewer reference memory errors than control
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animals receiving amphetamine injections. Also, control animals treated with saline showed a
continuous decrease in reference memory errors each week of the experiment, while control
animals treated with amphetamine showed no decrease in reference memory errors over the
course of the study. Thus, the results suggest that in control animals chronic amphetamine
treatment hindered their learning and memory of the maze.
Conversely, amphetamine did not appear to have the same hindering effect on reference
memory in SHR animals. Both the SHRs treated with saline and the SHRs treated with
amphetamine showed a slight learning curve illustrated by the slight decrease in frequency of
reference memory errors over the course of the experiment. There were also no significant
differences between the frequencies of reference memory errors during either of the three weeks
between the two SHR conditions. This is inconsistent with the hypothesis that amphetamine
would aid in learning and memory in SHRs. Overall, chronic amphetamine treatments showed
no hindering or enhancing effects on learning memory which is inconsistent with the known
positive effects of amphetamine treatment in children with ADHD. Therefore, further research
should be performed to confirm the validity of the model.
One finding that was consistent with the hypothesis was in the comparison of reference
memory errors in SHRs treated with saline and control animals treated with saline. Initially in
week one of training, there was no significant difference between the SHRs receiving saline
injections and the control animals receiving saline injections. However, by the second week of
training control animals treated with saline made fewer reference memory errors than SHRs
treated with saline. This trend continued in the third week of training, and again control animals
treated with saline made fewer reference memory errors than SHRs treated with saline.
Therefore, these results suggest that SHRs have more difficulty with learning and memory tasks
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than control animals, which is consistent with the results shown in Nakamura-Palacios, Caldas,
Fiorini, Chagas, Chagas, and Vasquez’s (1996) study that concluded that the SHR has a
deficiency in the performance of the radial maze, suggestive of impairment of learning and
working memory, mainly for a long-term memory. This suggests that deficits in learning and
memory are possible behavioral consequences of neural alterations associated with
catecholamine regulation.
Similar to the analysis of reference memory errors, the analysis of the frequency of
working memory errors did not support the hypotheses. In week one and two no significant
differences were observed in frequency of working memory errors between control animals
receiving daily saline injections and control animals receiving daily amphetamine injections.
However, by week three of the experiment, control animals treated with saline committed
significantly fewer working memory errors than control animals treated with amphetamine. This
trend suggests that chronic amphetamine treatment has a hindering effect on working memory in
control animals. Also, control animals treated with saline showed a continuous decrease in
working memory errors each week of the experiment, while control animals treated with
amphetamine showed little to no decrease in working memory errors over the course of the study.
Thus, the results suggest that inconsistent with the hypothesis, in control animals chronic
amphetamine treatment did not have beneficial effects on their learning and memory of the maze.
Chronic exposure to amphetamine could have caused addiction in animals receiving daily
amphetamine administration. Since the animals exposed to daily amphetamine treatments
showed decreased performance in the maze, it could be implicated that amphetamine addiction
played a role in the animals’ decreased performance. This is consistent with studies suggesting
that chronic psychostimulant abuse leads to significant cognitive impairments, especially in
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attention, working memory, and response inhibition functions (Sofuoglu, 2010). Robinson and
Kolb’s study (1999) extended the evidence for structural change after repeated injections of
psychostimulants, by showing morphological changes in the dendritic branching in the ventral
striatum and frontal cortex, which further highlighted the possibility that chronic
psychostimulant abuse may produce brain changes that lead to cognitive deficits. Another
rationale behind the decreased maze performance in animals receiving chronic amphetamine
administration could be amphetamine sensitization. Repeated amphetamine exposure can
produce reverse tolerance or sensitization to the psychological or locomotor-stimulating effects
of the drug. Sensitization refers to a progressive and persistent increase in a drug effect
produced by repeated drug administration (Anagnostaras & Robinson, 1996). Amphetamine
sensitization is suggested to lead to a reduction in prefrontal dopamine turnover, which is
associated with profound deficits in spatial working memory (Castner, Goldman-Rakic, &
Williams, 2004). In Hooks, Jones, Neill, and Justice’s (1992) study examining dose dependent
effects on amphetamine sensitization there was a pronounced sensitization to the locomotorstimulating properties of repeated 1.0 mg/kg amphetamine administration. Therefore, since the
rats in this study were also given repeated 1.0 mg/kg amphetamine administration, the decreased
maze performance could be a result of drug sensitization.
Conversely, amphetamine did not appear to have the same hindering effect on working
memory in SHR animals. There were also no significant differences between the frequencies of
working memory errors during either of the three weeks between the two SHR conditions. This
is inconsistent with the hypothesis that amphetamine would aid in learning and memory in SHRs.
Another finding that was consistent with the hypothesis was in the comparison of working
memory errors in SHRs treated with saline and control animals treated with saline. Initially in
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week one of training, there was no significant difference between the SHRs receiving saline
injections and the control animals receiving saline injections. However, by the second week of
training control animals treated with saline made fewer working memory errors than SHRs
treated with saline. This trend continued in the third week of training, and again control animals
treated with saline made fewer working memory errors than SHRs treated with saline. Therefore,
these results also suggest that SHRs have more difficulty with learning and memory tasks than
control animals.
As demonstrated in all three components of the RAM, chronic amphetamine
administration appeared to be more inhibiting in RAM performance in age/strain matched
control animals; whereas, chronic amphetamine administration did not enhance or inhibit RAM
performance in SHR animals. Since in humans amphetamine has been shown to have a
beneficial effect on learning and memory in individuals with ADHD, this suggests that the
neurophysiological mechanisms mediating learning and memory may be different in SHR
animals than humans with ADHD. Therefore, additional studies are needed to evaluate the
validity of the SHR as a model of ADHD.
On a behavioral level SHRs showed many different characteristics than control animals.
Although no quantifiable data was able to be gathered regarding behavioral differences, many
observable differences were witnessed through handling and exploration of the maze. In their
home cages, SHR animals appeared to be more social compared to control animals. The animals
would explore the cage together at most times, and when the cage was open both animals would
climb on one another to peak over the ledge of the cage. Similarly, during acclimation of the
maze the SHR animals explored the maze together and rarely separated; whereas, the control
animals were much more likely to separate and explore the maze on their own. Another
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observable difference was the SHRs overall hyperactivity and inattentiveness. Again, during
acclimation to the maze almost all of the SHR animals attempted to climb over the maze walls
rather than simply explore the maze. SHR animals also showed less interest in food rewards.
Conversely, during acclimation very few of the control animals attempted to climb over the walls
of the maze, and the control animals were overall more interested in food rewards during the
course of the study. This pattern of attempting to climb out of the maze persisted in the SHR
animals during training, while few control animals attempted to climb out of the maze at any
time of experimentation. These behavioral observations are consistent with other studies, such
as Mook’s (1993) study that concluded that SHR animals exhibit motor hyperactivity in a novel
environment, excessive responses under a fixed interval, and difficulty in acquiring operant tasks.
These abnormalities correlate to clinical features of hyperactivity, impulsivity, and learning
deficit seen in individuals with ADHD.

4.2 Immunohistochemistry
Although the immunohistochemistry process yielded no results, after witnessing the
behavioral results new hypotheses for c-Fos expression were formed. Prior to the study, the
greatest level in c-Fos expression in the hippocampus was thought to be observed in the control
animals receiving amphetamine treatments. However, initially the acute dose amphetamine
administration was thought to aid in learning and memory, yet the results of the study
demonstrated that acute dose amphetamine administration caused learning and memory deficits
in the control animals. Since a depletion of dopamine in the brain is associated with impairment
of memory and cognitive function and many physiological, pharmacological, and behavioral
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studies support the idea that dopamine acts as a neurotransmitter in the hippocampus and
modulate the activities of hippocampal neurons, the increased levels of dopamine released in the
brain as a result of acute dose amphetamine administration would theoretically cause an increase
in c-Fos expression in the hippocampus (Yokoyama, Okamura, & Ibata, 1995). Thus, the
hypothesis remains that the greatest c-Fos expression would be seen in the control animals
treated with amphetamine, yet unlike previously this level of neural activity or c-Fos expression
is no longer hypothesized to be helpful in learning and memory. In fact, hyperexpression of cFos might be the cause of the deficits in learning and memory witnessed in the control animals
given acute dose amphetamine administration.
Another hypothesis pertaining to c-Fos expression was that greater c-Fos expression
would be witnessed in SHR animals with amphetamine administration versus SHR animals with
saline administration. In retrospect, this hypothesis may be inconsistent with the behavioral
results. The behavioral results showed no significant differences between the two SHR treatment
groups; therefore, the SHR animals’ learning and memory was not benefited from chronic, acute
dose amphetamine administration. Since the learning and memory is associated with
hippocampal activity and the learning and memory of SHR animals were not inhibited or
enhanced by acute dose amphetamine administration, little to no difference in c-Fos expression
would be expected to be seen between the two SHR conditions.
The hypothesis that greater c-Fos expression would be witnessed in control animals with
saline administration compared to SHR animals with saline administration is consistent with the
behavioral results. The basis of this hypothesis stems from evidence that SHRs have deficits in
learning and memory (Nakamura-Palacios, et al., 1996). Thus SHR animals would be expected
to have less neural activity in the hippocampus since the hippocampus is critical in learning and
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memory. The behavioral results showed that control animals treated with saline showed better
learning and memory in the RAM than SHR animals treated with saline. Therefore, the
behavioral results suggest that greater neural activity in the hippocampus, expressed as c-Fos,
would be observed in control animals with saline administration rather than SHR animals with
saline administration.
Unfortunately, none of the previous hypotheses were able to be examined because of the
lack of c-Fos expression in the brain tissue. There are many potential explanations as to why the
immunohistochemistry procedure was unsuccessful. One of main potential reasons that no c-Fos
was detected could have been from the malfunction of the refrigerator. Approximately one week
after the completion of tissue cutting, the temperature of the refrigerator that is used to store the
cut tissue raised significantly. Other potential explanations as to why the immunohistochemistry
process was unsuccessful could be errors in any of the steps of the immunohistochemistry or
problems with one of the reagents. The immunohisochemistry procedure is a two day long
process with a number of integral steps. Therefore, if any of the incorrect reagents were used or
one of the steps was not properly performed then the immunohistochemistry process could have
been compromised.
In conclusion, the results of this study suggest that chronic amphetamine treatments have
detrimental effects on learning and memory in control rats. Unlike their age/strain matched
controls, amphetamine did not enhance or inhibit radial arm maze performance of SHR animals.
Since amphetamine is known to cause beneficial effects on learning and memory in children with
ADHD, this suggests that the neurophysiological mechanisms mediating learning and memory
may be different in SHR animals than in humans with ADHD. Therefore, additional studies are
needed to evaluate the validity of the SHR model of ADHD.
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Figure 1. The effects of amphetamine on radial arm maze performance in the SHR model of
ADHD vs. age/strain matched controls: Latency to maze completion

Figure 1. Average time to maze completion was quantified for each group during each week of
training. One-way ANOVAs revealed significant differences between groups on each week,
F(3,31)=4.482, p<0.01, F(3,31)=6.450, p<0.01, F(3,31)=14.48, p<0.01. A post hoc multiple
comparison Tukey HSD test suggested that acute dose amphetamine administration in age/strain
matched control animals initially enhanced maze performance; however, by week three acute
dose amphetamine administration appeared to hinder maze performance in age/strain matched
controls. Age/strain matched controls receiving saline administration also appeared to complete
the maze significantly faster than SHR animals receiving saline administration by the second and
third weeks.
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Figure 2. The effects of amphetamine on radial arm maze performance in age/strain matched
controls: Latency to maze completion

Figure 2. Performance of age/strain matched control animals in the radial arm maze was
quantified by the time it took the rats to retrieve all of the food rewards.
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Figure 3. The effects of amphetamine on radial arm maze performance in SHR model of ADHD
animals: Latency to maze completion

Figure 3. Performance of SHR animals in the radial arm maze was quantified by the time it took
the rats to retrieve all of the food rewards.
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Figure 4. The effects of amphetamine on radial arm maze performance in the SHR model of
ADHD vs. age/strain matched controls: Number of reference memory errors

Figure 4. Average number of reference memory errors was quantified for each group during each
week of training. One-way ANOVAs revealed significant differences between groups on week
one, (F(3,31)=9.556, p<0.01), and week two (F(3,31)=10.19, p<0.01). A post hoc multiple
comparison Tukey HSD test suggested that acute dose amphetamine administration in age/strain
matched control animals hindered maze performance by the second and third week compared to
age/strain matched controls receiving saline administration. Age/strain matched controls
receiving saline administration also appeared to commit fewer reference memory errors than
SHR animals receiving saline administration by the second and third weeks.

Amphetamine and ADHD
Figure 5. The effects of amphetamine on radial arm maze performance in age/strain matched
controls: Number of reference memory errors

Figure 5. Performance of age/strain matched control animals in the radial arm maze was
quantified by the number of reference memory errors made before retrieving all of the food
rewards.
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Figure 6. The effects of amphetamine on radial arm maze performance in SHR model of ADHD
animals: Number of reference memory errors

Figure 6. Performance of SHR animals in the radial arm maze was quantified by the number of
reference memory errors made before retrieving all of the food rewards.
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Figure 7. The effects of amphetamine on radial arm maze performance in the SHR model of
ADHD vs. age/strain matched controls: Number of working memory errors

Figure 7. Average number of working memory errors was quantified for each group during each
week of training. One-way ANOVAs revealed significant differences between groups on week
two, F(3,31)=9.486, p<0.01, and week three, F(3,31)=11.63, p<0.01. A post hoc multiple
comparison Tukey HSD test suggested that acute dose amphetamine administration in age/strain
matched control animals hindered maze performance by the second and third week compared to
age/strain matched controls receiving saline administration. Age/strain matched controls
receiving saline administration also appeared to commit fewer working memory errors than SHR
animals receiving saline administration by the second and third weeks.
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Figure 8. The effects of amphetamine on radial arm maze performance in age/strain matched
controls: Number of working memory errors

Figure 8. Performance of age/strain matched control animals in the radial arm maze was
quantified by the number of working memory errors made before retrieving all of the food
rewards.
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Figure 9. The effects of amphetamine on radial arm maze performance in SHR model of ADHD
animals: Number of working memory errors

Figure 9. Performance of SHR animals in the radial arm maze was quantified by the number of
working memory errors made before retrieving all of the food rewards.

